BioVersys and Enamine Announce Extension of Drug Discovery Collaboration to Address Multidrug-Resistant Bacterial Infections
04-Dec-2014
- Ukraine
Financial details were not disclosed. The IP generated by the collaboration is owned by BioVersys.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.